Zhejiang Cheng Yi Pharmaceutical Co Ltd Total Liabilities
Zhejiang Cheng Yi Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has total liabilities worth CN¥323.81 Million CNY (≈ $47.38 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Zhejiang Cheng Yi Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Total liabilities of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korea New Network Co. Ltd
KQ:058400
|
Korea | ₩13.88 Billion |
|
Kedge Construction Co Ltd
TW:2546
|
Taiwan | NT$10.54 Billion |
|
Jiangxi Huawu Brake Co Ltd
SHE:300095
|
China | CN¥1.10 Billion |
|
Chengdu Lihang Technology Co.Ltd.
SHG:603261
|
China | CN¥420.78 Million |
|
CHC Resources Corp
TW:9930
|
Taiwan | NT$5.29 Billion |
|
Tejon Ranch Co
NYSE:TRC
|
USA | $146.62 Million |
|
Kaiser China Holding Co Ltd
SHE:002425
|
China | CN¥419.04 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603811 asset base.
Liquidity & Leverage Metrics
Zhejiang Cheng Yi Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhejiang Cheng Yi Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Cheng Yi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual total liabilities of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥304.55 Million ≈ $44.57 Million |
-34.27% |
| 2024-12-31 | CN¥463.31 Million ≈ $67.80 Million |
-33.45% |
| 2023-12-31 | CN¥696.15 Million ≈ $101.87 Million |
+10.82% |
| 2022-12-31 | CN¥628.16 Million ≈ $91.92 Million |
+94.11% |
| 2021-12-31 | CN¥323.62 Million ≈ $47.36 Million |
+0.88% |
| 2020-12-31 | CN¥320.79 Million ≈ $46.94 Million |
+51.83% |
| 2019-12-31 | CN¥211.29 Million ≈ $30.92 Million |
+48.33% |
| 2018-12-31 | CN¥142.45 Million ≈ $20.84 Million |
+94.04% |
| 2017-12-31 | CN¥73.41 Million ≈ $10.74 Million |
-12.72% |
| 2016-12-31 | CN¥84.11 Million ≈ $12.31 Million |
-2.44% |
| 2015-12-31 | CN¥86.21 Million ≈ $12.62 Million |
+4.16% |
| 2014-12-31 | CN¥82.77 Million ≈ $12.11 Million |
-37.50% |
| 2013-12-31 | CN¥132.43 Million ≈ $19.38 Million |
-26.42% |
| 2012-12-31 | CN¥179.99 Million ≈ $26.34 Million |
-6.78% |
| 2011-12-31 | CN¥193.09 Million ≈ $28.25 Million |
-- |
About Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, cap… Read more